Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Current Leases (2019 - 2025)

Historic Current Leases for Macrogenics (MGNX) over the last 7 years, with Q3 2025 value amounting to $5.1 million.

  • Macrogenics' Current Leases rose 836.85% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 836.85%. This contributed to the annual value of $4.9 million for FY2024, which is 2884.77% up from last year.
  • Latest data reveals that Macrogenics reported Current Leases of $5.1 million as of Q3 2025, which was up 836.85% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Current Leases ranged from a high of $5.4 million in Q1 2025 and a low of $3.8 million during Q4 2023
  • Over the past 5 years, Macrogenics' median Current Leases value was $4.7 million (recorded in 2021), while the average stood at $4.6 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 3639.9% in 2021, then tumbled by 2180.84% in 2023.
  • Macrogenics' Current Leases (Quarter) stood at $4.7 million in 2021, then increased by 1.05% to $4.7 million in 2022, then decreased by 20.12% to $3.8 million in 2023, then rose by 28.85% to $4.9 million in 2024, then grew by 5.69% to $5.1 million in 2025.
  • Its Current Leases stands at $5.1 million for Q3 2025, versus $5.1 million for Q2 2025 and $5.4 million for Q1 2025.